FDA Wants Feedback on Sterilizing Device Shipping Forms – Yawn?
Published Date: 7/2/2025
Notice
Summary
The FDA wants your thoughts on a new form that helps track medical devices shipped for sterilization or extra work. This affects companies sending devices to be cleaned or repackaged, and the agency is asking for comments within 60 days. No big costs or changes yet—just making sure the paperwork is clear and easy to handle!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New Shipment Form for Sterilization
The FDA is asking for public comment on a proposed form to track nonsterile medical devices that are shipped to other establishments for sterilization, processing, labeling, or repacking. The agency is accepting comments for 60 days under the Paperwork Reduction Act of 1995. This change affects companies that send devices to be cleaned or repackaged.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11966 — Forms FDA 3542a and FDA 3542: Questions and Answers; Draft Guidance for Industry; Availability
The FDA just dropped a draft guide to help businesses fill out Forms FDA 3542a and FDA 3542 without confusion. If you submit these forms, this guide answers your top questions and makes the process smoother. You’ve got until August 14, 2026, to send in your feedback before the FDA finalizes the guide—no extra costs, just clearer steps!
2026-11998 — Amendment and Revocation of Organizational Information Regulations
The FDA is updating its rules to point everyone to its website for the latest contact and organizational info, ditching old, unnecessary regulations. This makes it easier for the public to find accurate info all in one place, starting June 15, 2026. If you interact with the FDA, expect smoother access with no extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
Previous / Next Documents
Previous: 2025-12304 — Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing of Amendment No. 1 to Proposed Rule Change To Amend NYSE Arca Rule 8.500-E and To List and Trade Shares of the Grayscale Digital Large Cap Fund LLC
NYSE Arca wants to update its rules to let people buy and sell shares of the Grayscale Digital Large Cap Fund LLC, a fund focused on digital assets like cryptocurrencies. This change affects investors interested in digital and commodity-based funds and could open new ways to invest starting soon. The SEC is reviewing the proposal, and if approved, trading could begin later in 2025, potentially impacting how digital assets are traded on the exchange.
Next: 2025-12307 — Agency Information Collection Activities; Proposed Collection; Comment Request; Environmental Impact Considerations
The FDA wants your thoughts on how it collects info about environmental impacts. This is a chance for anyone affected—like businesses and the public—to share feedback before the agency updates its forms. You’ve got 60 days to weigh in, and no new costs are expected right now.